GitLab vs. Oracle: Which Technology Stock Is a Better Buy in 2026?

GitLab generated about $955.2 million in FY2026 revenue, up roughly 25.8%, but remained unprofitable with a net loss of about $56 million despite $222 million of free cash flow. Oracle posted nearly $67.4 billion of FY2026 revenue, up about 17.4%, with $17.1 billion of net income and a 25.4% margin, though free cash flow was negative $23.7 billion due to heavy AI and cloud infrastructure spending. The article favors Oracle for its scale, profitability, and backlog, while flagging GitLab’s growth, competition, and litigation risks.

Analysis

The key second-order dynamic is that both names are being priced as AI beneficiaries, but only one has already converted capex into contracted demand. That makes the market more willing to forgive Oracle’s leverage and near-term cash burn because backlog visibility shortens the payback period on infrastructure spend; in contrast, GitLab still has to prove that AI-assisted developer workflows materially expand seat count and retention rather than just deepen product usage among existing customers. In other words, ORCL is moving from story stock to utility-like backlog monetization, while GTLB remains a distribution-and-expansion bet.

Competitively, GitLab is more exposed to bundling pressure from larger platforms that can subsidize development tooling to protect broader cloud and productivity franchises. The risk is not outright share loss in the next quarter, but slower net retention and longer sales cycles as buyers rationalize tool sprawl under tighter budgets. Oracle’s competitive edge is different: it can cross-subsidize data center growth with cash flow from legacy database and enterprise software, making it harder for pure-play infrastructure rivals to match on financing intensity.

The bigger risk on Oracle is not demand, but execution on power, hardware, and build-out cadence over the next 12-24 months. If supply constraints or regulatory delays slow capacity delivery, the valuation can compress quickly because the market is already underwriting a multi-year AI ramp. For GitLab, the catalyst path is sharper but smaller: any evidence that AI features reduce churn or lift enterprise deal sizes could rerate the stock, but absent that, it risks becoming a high-quality subscale compounder with a persistent profitability discount.

Consensus appears to be underweighting how much capital intensity matters for the current AI cycle. Investors are rewarding AI exposure broadly, but the winners are increasingly the names that can finance infrastructure without continuous equity dilution or margin degradation. That argues for owning the balance-sheet-backed enabler over the specialty software challenger until GTLB demonstrates a cleaner path from growth to durable operating leverage.

Key Decisions for Investors

• Long ORCL / short GTLB pair trade for the next 6-12 months: express a preference for contracted AI infrastructure monetization over speculative SaaS expansion; target ~15-20% relative outperformance if Oracle backlog converts cleanly and GitLab remains cash-flow-heavy.
• Buy ORCL on pullbacks rather than strength; use any post-earnings or litigation-driven selloff as an entry because the risk/reward improves once valuation de-risks while backlog remains intact.
• Sell GTLB rallies or fade momentum via covered calls over the next 1-2 quarters; the stock needs clear evidence of operating leverage, and absent that, upside is likely capped by profitability skepticism.
• If seeking convexity, use GTLB call spreads only around product/catalyst events tied to AI workflow adoption; keep small size because the thesis depends on monetization proof, not just feature launches.
• Monitor Oracle’s capex-to-bookings conversion and capacity delivery timelines over the next 2 quarters; if delays emerge, reduce ORCL exposure quickly because the stock is vulnerable to multiple compression once infrastructure growth loses visibility.